| Parameter | Value | Meaning |
|---|---|---|
| V0 | 0 | Initial velocity |
| Vmax | 100 | Maximum velocity (all enzyme saturated) |
| Km | 25 | [S] at which V0 = ½Vmax |
| [S]/Km | 1.2 | Saturation ratio |
| Apparent Km | 25 | Effective Km with inhibitor |
| Apparent Vmax | 100 | Effective Vmax with inhibitor |
Michaelis-Menten Enzyme Kinetics
How enzymes catalyze reactions and how we measure their efficiency
Enzymes are nature's catalysts, accelerating reactions by factors of 105 to 1017. In 1913, Leonor Michaelis and Maud Menten proposed that an enzyme (E) reversibly binds its substrate (S) to form an ES complex, which then breaks down to yield product (P) and free enzyme. Briggs and Haldane (1925) placed this on a firmer kinetic footing using the steady-state assumption.
Below, watch enzyme molecules bind substrates (blue) and release products (orange). Adjust substrate concentration, Vmax, and Km to see how initial velocity V0 follows the hyperbolic Michaelis-Menten curve—and how inhibitors shift it.
What you are looking at
The chamber above shows a schematic of a reaction vessel, not a literal slice of solution. The 12 large green circles are individual enzyme molecules (E). The small blue dots are substrate molecules (S); their count scales with [S]: at 30 mM roughly 18 dots are shown, at 200 mM roughly 120. In reality a 30 mM solution contains around 1.8×1022 molecules per liter—the cartoon simply makes the proportionality visible.
What is physically meaningful: the fraction of enzymes in the ES state (labeled "ES," darker green) approximates the true steady-state fraction [ES]/[Et] = [S]/(Km + [S]). Drag [S] far above Km and nearly every enzyme is bound; drag it well below Km and most enzymes sit idle as free E. Each time an ES complex completes catalysis, an orange product dot appears and the enzyme immediately re-enters the free pool. The rate at which you see orange flashes is proportional to V0.
The reaction mechanism
The two-step scheme underlying the simulation is:
Michaelis and Menten (1913) derived the rate law assuming rapid equilibrium between E+S and ES. Briggs and Haldane (1925) showed the same equation follows from the more general steady-state assumption: [ES] is constant because its rate of formation (k1[E][S]) equals its total rate of breakdown (k-1[ES] + kcat[ES]). Solving for [ES] and substituting V0 = kcat[ES] gives:
The V0 vs [S] curve
The upper graph plots V0 against [S]; the red dot is your current slider position. At low [S] (few blue dots, most enzymes labeled E) the dot sits on the nearly-linear rising portion: [S] << Km, so Km + [S] ≈ Km and
Drag [S] far above Km (the dashed vertical marker on the curve) and the dot climbs toward the plateau: [S] >> Km, so Km + [S] ≈ [S] and V0 ≈ Vmax. In the chamber nearly all enzymes are in the ES state; adding more blue dots cannot speed things up because every active site is already occupied. This saturation is the hallmark of enzyme kinetics. Km is defined as the [S] at which V0 = ½ Vmax:
Note that Km equals the true equilibrium dissociation constant Kd = k-1/k1 only in the rapid-equilibrium limit (kcat << k-1); in general Km reflects both binding affinity and the catalytic rate.
The Lineweaver-Burk plot
The lower graph is a double-reciprocal (Lineweaver-Burk) plot: 1/V0 on the y-axis, 1/[S] on the x-axis. Taking the reciprocal of the Michaelis-Menten equation rearranges it into a linear form:
The red dot in the Lineweaver-Burk plot is the same operating point (1/[S], 1/V0) as on the MM curve above—move the [S] slider and watch both dots move simultaneously. The red markers on the axes label the intercepts. This linearization was historically essential for extracting Km and Vmax from experimental data before nonlinear curve fitting was routine; today it is mainly useful for visually diagnosing inhibition type (see below).
Enzyme inhibition
Select an inhibitor type in the controls and raise [I]. Watch what changes in the chamber, the MM curve, and the Lineweaver-Burk plot. The ghost curve (dashed) shows the uninhibited baseline for comparison.
Competitive inhibition (select it and watch the chamber): some free enzymes turn red and are labeled EI—the inhibitor has entered the active site and physically blocked substrate from binding. Free E can be either EI or available; bound ES enzymes are unaffected. On the MM curve the plateau (Vmax) is unchanged but the curve is shifted right: apparent Km = αKm. High [S] can always outcompete the inhibitor, so the dashed Km marker moves right while the Vmax dashed line stays put. On the Lineweaver-Burk plot the lines fan out from the same y-intercept (1/Vmax unchanged) with steeper slopes (αKm/Vmax).
Uncompetitive inhibition: the inhibitor cannot bind free enzyme at all—it binds only to the ES complex at a site remote from the active site, forming ESI. In the chamber, free enzymes (E) remain green; it is the bound ES complexes that sometimes turn red (ESI) and stall. Because ESI pulls the E+S ⇌ ES equilibrium toward ES, the enzyme actually appears to bind substrate more tightly: apparent Km = Km/α′ decreases. Apparent Vmax = Vmax/α′ also decreases because a fraction of ES is stuck as ESI. On the Lineweaver-Burk plot both intercepts shift by the same factor α′, giving parallel lines—the diagnostic signature of uncompetitive inhibition.
Mixed inhibition: the inhibitor can bind either free E (forming EI, labeled red in the chamber) or ES (forming ESI, also red). Both α and α′ are > 1, so both apparent Km and apparent Vmax change. When α = α′ (equal affinity for E and ES) this reduces to noncompetitive inhibition: Km is unchanged but Vmax decreases; on the Lineweaver-Burk plot the lines intersect on the x-axis.